Centre Hospitalier Henri Laborit
Poitiers, France
Location status: Recruiting
NCT Number: NCT06017713
This is a single-center study about patients with severe resistant OCD.
Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex, and the cathode at the level of the supplementary motor area, associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms.
After the inclusion visit, the treatment period is provided from D1 to D12 (one session per day from Monday to Friday, for two consecutive weeks, i.e. a total of ten sessions). Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel.
The patients are then assessed on D42 and D102 (i.e. 1 month and 3 months after the end of the tDCS sessions).
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Poitiers, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Generalized anxiety disorder, social phobia, nicotine addiction and history of major depressive episodes are not exclusion criteria. Axis I comorbidity will be explored using MINI 5.0.0. ;
The treatment consists of 10 sessions of tDCS. Each tDCS session lasts 30 minutes at an intensity of 2mA and is preceded by a provocation of symptoms.
Time frame: 3,5 months
The primary endpoint corresponds to the change in the score on the YBOCS scale between the inclusion visit (Day 0) and the Day 42 visit.
A score of 0 corresponds to the absence of OCD and a score of 40 to maximum severity.
Interested in participating?
Request InfoCentre Hospitalier Henri Laborit
Other
Direct Transcranial Stimulation With Direct Current Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive
Acronym: PPSTDCS-TOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04131829
Anxiety Disorders, Mental Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT06582225
Anxiety Disorders, Autism Spectrum Disorder
Lund, Skåne County, Sweden
View Trial DetailsNCT07065669
Anxiety Disorders, Mental Disorders
San Francisco, California, United States
View Trial DetailsNCT05931913
Anxiety Disorders, Mental Disorders
Minneapolis, Minnesota, United States
View Trial Details